Skip to main content

Allogeneic stem cell transplantation


Allogeneic stem cell transplantation is an established form of treatment of leukemias, some other serious hematological illnesses and some rare illnesses of the immunological system.

The most common indication for allogeneic stem cell transplantation for adults is acute myelogeneic leukemia (AML). The transplanted tissue in allogeneic stem cell transplantation is collected from another person whose tissue type is compatible with the tissue type of the patient (recipient). 

In allogeneic stem cell transplantation, the diseased bone marrow of the patient is first destroyed with the use of what is called a conditioning regimen and the patient’s immune system is blocked with the use of medication. This is done to avoid the stem cells of the donor from becoming rejected. The purpose is to have the allogeneic stem cells engrafted and to have them populate the recipient’s bone marrow. The immunological cells in the donor cell transplant will replace the patient’s original bone marrow and destroy any remaining malignant cells. The intention of an allogeneic stem cell transplantation is always cure.

Treatment facilities

Stem cell transplantation unit

At our unit we perform allogeneic as well as autologous stem cell transplantations.

Hematology Ward

At the hematology ward we examine and treat adult patients with hematological (blood) diseases.

Hematology Outpatient Clinic, T-Hospital

We examine and treat adult patients with hematological (blood) diseases.